ATE91419T1 - Synergistische kombination zur ophthalmischen verwendung. - Google Patents

Synergistische kombination zur ophthalmischen verwendung.

Info

Publication number
ATE91419T1
ATE91419T1 AT91304573T AT91304573T ATE91419T1 AT E91419 T1 ATE91419 T1 AT E91419T1 AT 91304573 T AT91304573 T AT 91304573T AT 91304573 T AT91304573 T AT 91304573T AT E91419 T1 ATE91419 T1 AT E91419T1
Authority
AT
Austria
Prior art keywords
ophthalmic use
synergic combination
pharmaceutically acceptable
combination
synergic
Prior art date
Application number
AT91304573T
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ATE91419T1 publication Critical patent/ATE91419T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
AT91304573T 1990-05-22 1991-05-21 Synergistische kombination zur ophthalmischen verwendung. ATE91419T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13291190 1990-05-22

Publications (1)

Publication Number Publication Date
ATE91419T1 true ATE91419T1 (de) 1993-07-15

Family

ID=15092409

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91304573T ATE91419T1 (de) 1990-05-22 1991-05-21 Synergistische kombination zur ophthalmischen verwendung.

Country Status (8)

Country Link
EP (1) EP0458587B1 (de)
JP (1) JP2511586B2 (de)
KR (1) KR960010436B1 (de)
AT (1) ATE91419T1 (de)
CA (1) CA2042936C (de)
DE (1) DE69100171T2 (de)
DK (1) DK0458587T3 (de)
ES (1) ES2059058T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565492A (en) * 1988-07-18 1996-10-15 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
AU665287B2 (en) * 1992-12-21 1995-12-21 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
AR002194A1 (es) * 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.
US6770675B2 (en) 1997-03-17 2004-08-03 Novartis Ag Compositions and methods for reducing ocular hypertension
US7186744B2 (en) * 2003-11-13 2007-03-06 Allergan, Inc. Prostamides for the treatment of glaucoma and related diseases
WO2006041875A1 (en) 2004-10-06 2006-04-20 Allergan, Inc. Novel prostamides for the treatment of glaucoma and related diseases
GB201418567D0 (en) * 2014-10-20 2014-12-03 Syngenta Participations Ag Improvements in or relating to organic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
ATE76750T1 (de) * 1987-04-03 1992-06-15 Univ Columbia Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes.
JPH0739343B2 (ja) * 1988-10-01 1995-05-01 株式会社アールテック・ウエノ 眼圧降下剤
ATE82499T1 (de) * 1987-09-18 1992-12-15 R Tech Ueno Ltd Okulare hypotensivagenzien.

Also Published As

Publication number Publication date
JP2511586B2 (ja) 1996-06-26
EP0458587A1 (de) 1991-11-27
DE69100171D1 (de) 1993-08-19
CA2042936A1 (en) 1991-11-23
DK0458587T3 (da) 1993-08-23
CA2042936C (en) 2002-04-30
ES2059058T3 (es) 1994-11-01
KR960010436B1 (ko) 1996-08-01
KR910019622A (ko) 1991-12-19
DE69100171T2 (de) 1993-10-28
JPH04253913A (ja) 1992-09-09
EP0458587B1 (de) 1993-07-14

Similar Documents

Publication Publication Date Title
DK1920764T4 (da) Fluprostenolisopropylester til anvendelse ved behandling af glaukom og okulær hypertension
NO891909D0 (no) Implantat for brytningskorreksjon i et oeyes forkammer.
DK0668763T3 (da) Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme
DE69719931T2 (de) Verwendung von Acetylcystein zur Herstellung eines Arzneimittels zur Behandlung von chronischen Geschwüren
DK0501705T3 (da) Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
DE69105349D1 (de) Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung.
ES2069823T3 (es) Tratamiento de la hipertension ocular con una combinacion sinergica ocular.
ATE91419T1 (de) Synergistische kombination zur ophthalmischen verwendung.
ES2084771T3 (es) Tratamiento de la hipertension ocular con la ayuda de una combinacion sinergica.
AU1656997A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
DE69301387T2 (de) Behandlung des Glaukoms mit synergistischer Kombination
ES2089387T3 (es) Tratamiento de la hipertension ocular con la ayuda de una combinacion sinergica.
GR3022706T3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
DE551180T1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DK0711163T3 (da) Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF
DE69800906T2 (de) Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie
DE69804034T2 (de) Verwendung von Olanzapin zur Herstellung eines Arzneimittels zur Neuroprotektion

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee